Head-to-head · Value Score
Alan Meds vs MyFastRx
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, MyFastRx a 81. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#7 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameMyFastRx
#57 · Grade B · Good Value
Est. first month
From $99/mo (12-month plan, compounded)
Save ~93% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 81 — an est. $99/mo first month, with no teaser step-up baked in. MyFastRx isn't out of it: Shoppers who want cash-pay patients comfortable with 12-month upfront billing for the lowest compounded-GLP-1 monthly rate.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | MyFastRx |
|---|---|---|
| Value Score | 90 (A) | 81 (B) |
| Est. first month | $99/mo | From $99/mo (12-month plan, compounded) |
| Save vs brand-name | ~93% | ~93% |
| Semaglutide | $99/mo | From $99/mo (12-month plan, compounded) |
| Tirzepatide | $145/mo | From $149/mo (12-month plan, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
MyFastRx
MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.
Why it's a deal
- Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
- LegitScript certified
- All doses priced the same — no cost escalation as you titrate up
- First-month promo discount lowers the trial barrier
The fine print
- States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
- Corporate address and medical director not published
- Pharmacy partner not named — only 'state-licensed pharmacies'
- Cash-pay only — no insurance billing
- Bundle savings require a large upfront commitment (12 months billed at once)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to MyFastRx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.